Opinion https://www.benzinga.com/views/taxonomy/term/146540 en A Repeat of 2000 And 2008 Luming? A Critical Look At The S&P 500. https://www.benzinga.com/opinion/22/10/29141498/a-repeat-of-2000-and-2008-luming-a-critical-look-at-the-s-p-500 <p>The S&amp;P 500 has declined by 17% since the high of August. This includes a further decline of 11% since <a href="https://www.benzinga.com/trading-ideas/22/09/28814607/how-to-indentify-the-end-of-the-decline-on-the-s-p-500">my last update</a>.&nbsp;</p> <p>The price made light work of the trendline I highlighted in my previous article, breaking through it and declining further to the weekly 200 simple moving average (w200sma), where the price is now finding support.&nbsp;</p> <p><strong>Below I have the weekly timeframe of the S&amp;P 500</strong></p> <p><img alt="screenshot_2022-10-04_at_10.59.30_pm.png" src="https://cdn.benzinga.com/files/u240220/screenshot_2022-10-04_at_10.59.30_pm.png" style="height:338px; width:650px" /></p> <p>Ignoring the 35% decline caused by CV19, the last time we saw the price break and close below the w200sma, which materialised into a bear market, was during the financial meltdown of 2008. The price then declined by a further 50%.</p> <p>Below is the weekly timeframe of the S&amp;P 500.</p> <p>Since moving back above in 2010, the price has used the w200sma as support in 2011, 2016 and 2018.</p> <p>The question is, ...</p><p><a href=https://www.benzinga.com/opinion/22/10/29141498/a-repeat-of-2000-and-2008-luming-a-critical-look-at-the-s-p-500 alt=A Repeat of 2000 And 2008 Luming? A Critical Look At The S&amp;P 500.>Full story available on Benzinga.com</a></p> contributors S&P 500 Opinion Markets Opinion Markets Benzinga Tue, 04 Oct 2022 17:28:34 +0000 Zaheer Anwari 29141498 at https://www.benzinga.com Thinking about buying stock in Bit Brother, Carnival Corp, Nio, Ford, or FingerMotion? https://www.benzinga.com/pressreleases/22/10/n29138826/thinking-about-buying-stock-in-bit-brother-carnival-corp-nio-ford-or-fingermotion <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3667216-1&amp;h=18218616&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100420225&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for BTB, CCL, NIO, F, and FNGR.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29138826/thinking-about-buying-stock-in-bit-brother-carnival-corp-nio-ford-or-fingermotion alt=Thinking about buying stock in Bit Brother, Carnival Corp, Nio, Ford, or FingerMotion?>Full story available on Benzinga.com</a></p> Banking/Financial Services BTB CCL F FNGR NIO Opinion Press Releases Tue, 04 Oct 2022 15:01:00 +0000 PRNewswire 29138826 at https://www.benzinga.com Thinking about trading options or stock in Diamondback Energy, T-Mobile, Apple, NVIDIA, or Coinbase Global? https://www.benzinga.com/pressreleases/22/10/n29136918/thinking-about-trading-options-or-stock-in-diamondback-energy-t-mobile-apple-nvidia-or-coinbase-gl <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3667106-1&amp;h=1828336507&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fprnumber%3D100420223&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for FANG, TMUS, AAPL, NVDA, and COIN.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29136918/thinking-about-trading-options-or-stock-in-diamondback-energy-t-mobile-apple-nvidia-or-coinbase-gl alt=Thinking about trading options or stock in Diamondback Energy, T-Mobile, Apple, NVIDIA, or Coinbase Global?>Full story available on Benzinga.com</a></p> AAPL Banking/Financial Services COIN FANG NVDA TMUS Opinion Press Releases Tue, 04 Oct 2022 13:35:00 +0000 PRNewswire 29136918 at https://www.benzinga.com Thinking about trading options or stock in Laredo Petroleum, Repligen, Tesla, Amazon, or Advanced Micro Devices? https://www.benzinga.com/pressreleases/22/10/n29136917/thinking-about-trading-options-or-stock-in-laredo-petroleum-repligen-tesla-amazon-or-advanced-micr <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3667106-3&amp;h=1095071302&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fprnumber%3D100420224&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for LPI, RGEN, TSLA, AMZN, and AMD.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29136917/thinking-about-trading-options-or-stock-in-laredo-petroleum-repligen-tesla-amazon-or-advanced-micr alt=Thinking about trading options or stock in Laredo Petroleum, Repligen, Tesla, Amazon, or Advanced Micro Devices?>Full story available on Benzinga.com</a></p> AMD AMZN Banking/Financial Services LPI RGEN TSLA Small Cap Opinion Press Releases Tue, 04 Oct 2022 13:35:00 +0000 PRNewswire 29136917 at https://www.benzinga.com Thinking about buying stock in Inhibrx, Playtika, Poshmark, Vir Biotechnology, or Ferroglobe? https://www.benzinga.com/pressreleases/22/10/n29136916/thinking-about-buying-stock-in-inhibrx-playtika-poshmark-vir-biotechnology-or-ferroglobe <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3667106-2&amp;h=499027879&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100420222&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for INBX, PLTK, POSH, VIR, and GSM.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29136916/thinking-about-buying-stock-in-inhibrx-playtika-poshmark-vir-biotechnology-or-ferroglobe alt=Thinking about buying stock in Inhibrx, Playtika, Poshmark, Vir Biotechnology, or Ferroglobe?>Full story available on Benzinga.com</a></p> Banking/Financial Services GSM INBX PLTK POSH VIR Opinion Press Releases Tue, 04 Oct 2022 13:35:00 +0000 PRNewswire 29136916 at https://www.benzinga.com Hemp Company Starts Selling Hemp Cigarettes Branded After Famous Comedy Duo https://www.benzinga.com/pressreleases/22/10/n29135070/hemp-company-starts-selling-hemp-cigarettes-branded-after-famous-comedy-duo <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">FN Media Group Presents Microsmallcap.com Market Commentary</i></b></p> <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- Hempacco, a vertically integrated hemp manufacturing company, began <u xmlns="http://www.w3.org/1999/xhtml"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.cannabisbusinesstimes.com/article/hempacco-commences-sales-of-cheech-and-chong-branded-cbd-cigarettes/" target="_blank" rel="nofollow" rel="nofollow">selling</a></u> Cheech &amp; Chong branded hemp smoking products in the third quarter of 2022 as part of its joint venture 50/50 previously announced. In <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">January 2022</span>, Hempacco entered into a joint venture agreement with Cheech and Chong&#39;s Cannabis Company (CCCC). Hempacco launched its first line of Cheech &amp; Chong-branded hemp smoking products and hemp packaging, as well as a Cheech &amp; Chong-branded kiosk vending machine, with <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Tommy Chong</span>, at the Tobacco Plus Expo in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Las Vegas</span> in January. Of course, <b xmlns="http://www.w3.org/1999/xhtml">Hempacco Co., Inc. </b>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPCO#NASDAQ" rel="nofollow">HPCO</a>) isn&#39;t the only company providing new products to the market. <b xmlns="http://www.w3.org/1999/xhtml">The Hempshire Group </b>(TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HMPG#TSXV" rel="nofollow">HMPG</a>) (OTCPK:HMPSF),<b xmlns="http://www.w3.org/1999/xhtml"> MariMed, Inc </b>(CSE:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#CSE" rel="nofollow">MRMD</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTCQX" rel="nofollow">MRMD</a>),<b xmlns="http://www.w3.org/1999/xhtml"> MedMen Enterprises Inc. </b>(CSE:<a class="ticker" href="https://www.benzinga.com/stock/MMEN#CSE" rel="nofollow">MMEN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MMNFF#OTCQX" rel="nofollow">MMNFF</a>), and<b xmlns="http://www.w3.org/1999/xhtml"> Tilray Brands Inc </b>(TSX:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#TSX" rel="nofollow">TLRY</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ" rel="nofollow">TLRY</a>) also expanding their product lines.</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">The Hempshire Group (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/HMPG#TSXV" rel="nofollow">HMPG</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HMPSF#OTC" rel="nofollow">HMPSF</a>)</b> is a <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">California</span>-based smokable alternatives company formulating and selling its own proprietary brand of organic hemp smokes under the MOUNTAIN Smokes brand name. Hempshire also provides private white-labelling services and contract manufacturing services through its partners for significant non-owned Hemp Smoke brands in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">the United States</span> and internationally.</p> <p xmlns="http://www.w3.org/1999/xhtml">On <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">October 4</span>, <b xmlns="http://www.w3.org/1999/xhtml">Hempshire</b> announced the execution of strategic partnership agreements with <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Amit Khubani</span> and <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Tom Patterson</span>. Khubani is part of the family who founded Telebrands, the &#34;As Seen On TV&#34; marketing empire, ONTEL Products Corp, and Idea Village. He serves as the Executive VP of ONTEL, overseeing product sales generation of over <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$500 million</span> annually; Patterson is recognized as one of the leading growth marketing and digital marketing strategists in ecommerce. Patterson&#39;s in-house owned brands have generated over <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">US$100 million</span> in consumer and B2B sales, and he has been responsible for over <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">US$450 million</span> in product sales for clients of his marketing agency, WKND Digital.</p> <p xmlns="http://www.w3.org/1999/xhtml">The partnership agreements are performance-based and designed to incentivize Khubani and Patterson to drive <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">$10 million</span> in B2B product sales for The <b xmlns="http://www.w3.org/1999/xhtml">Hempshire</b> Group over the next twelve months in exchange for equity in the company.</p> <p xmlns="http://www.w3.org/1999/xhtml">&#34;We are ecstatic to have attracted two high-caliber individuals to Hempshire&#39;s U.S. B2B sales efforts, and even more excited that these individuals have requested a highly incentivized performance and equity based compensation structure,&#34; said <span xmlns="http://www.w3.org/1999/xhtml" class="xn-person">Martin Marion</span>, <b xmlns="http://www.w3.org/1999/xhtml">Hempshire</b> President and CEO. &#34;After trying MOUNTAIN&#xAE; Smokes within their circles and conducting their due diligence, Amit and Tom&#39;s request for a performance and equity-based compensation package shows their belief in the upside potential of Hempshire.&#34;</p> <p xmlns="http://www.w3.org/1999/xhtml">Last month, <b xmlns="http://www.w3.org/1999/xhtml">Hempshire Group</b> expanded its international reach after <u xmlns="http://www.w3.org/1999/xhtml"><a xmlns="http://www.w3.org/1999/xhtml" href="https://pressreach.com/featured-news/hempshire-signs-a-1.25-million-purchase-agreement-for-the-sale-of-mountain-smokes-in-europe-and-the-eu" target="_blank" rel="nofollow" rel="nofollow">signing</a></u> a contractual <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">US$1.25 million</span> purchase deal for MOUNTAIN&#xAE; Smokes destined for <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Europe</span> and the European Union with European exclusive master distributor Montagnaria Group AG (EU).</p> <p xmlns="http://www.w3.org/1999/xhtml">The purchase agreement follows <b xmlns="http://www.w3.org/1999/xhtml">Hempshire</b>&#39;s recent clearance to sell MOUNTAIN&#xAE; Smokes in <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Belgium</span>, allowing access to the entire EU through member state reciprocity, as previously disclosed in a press release dated <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">September 7, 2022</span>.</p> <p xmlns="http://www.w3.org/1999/xhtml">Montagnaria&#39;s binding promise to purchase a minimum of <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">US$1.25 million</span> of MOUNTAIN&#xAE; Smokes throughout the twelve months from <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">September 2022</span> to <span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">August 2023</span> is included in the Purchase Agreement. All purchase orders issued under the Purchase Agreement require payment of 50% of the total purchase order upon issuing and ...</p><p><a href=https://www.benzinga.com/pressreleases/22/10/n29135070/hemp-company-starts-selling-hemp-cigarettes-branded-after-famous-comedy-duo alt=Hemp Company Starts Selling Hemp Cigarettes Branded After Famous Comedy Duo>Full story available on Benzinga.com</a></p> Banking/Financial Services CSE:MMEN CSE:MRMD HMPSF HPCO MMNFF MRMD TLRY TSX:TLRY TSXV:HMPG Small Cap Opinion Press Releases Tue, 04 Oct 2022 12:50:00 +0000 PRNewswire 29135070 at https://www.benzinga.com Thinking about buying stock in Connect Biopharma, Rivian Automotive, AeroClean Technologies, Kiora Pharmaceuticals, or Humanigen? https://www.benzinga.com/pressreleases/22/10/n29134492/thinking-about-buying-stock-in-connect-biopharma-rivian-automotive-aeroclean-technologies-kiora-ph <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3667043-1&amp;h=2606019&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100420221&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for CNTB, RIVN, AERC, KPRX, and HGEN.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29134492/thinking-about-buying-stock-in-connect-biopharma-rivian-automotive-aeroclean-technologies-kiora-ph alt=Thinking about buying stock in Connect Biopharma, Rivian Automotive, AeroClean Technologies, Kiora Pharmaceuticals, or Humanigen?>Full story available on Benzinga.com</a></p> AERC Banking/Financial Services CNTB HGEN KPRX RIVN Small Cap Opinion Press Releases Tue, 04 Oct 2022 12:30:00 +0000 PRNewswire 29134492 at https://www.benzinga.com Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand https://www.benzinga.com/pressreleases/22/10/n29134483/global-laser-therapy-devices-billion-dollar-market-thriving-on-growing-demand <p xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml"><u xmlns="http://www.w3.org/1999/xhtml"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.financialnewsmedia.com/" target="_blank" rel="nofollow" rel="nofollow">FinancialNewsMedia.com</a></u> News Commentary</i></p> <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">PALM BEACH, Fla.</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 4, 2022</span></span> /PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years. Minimally invasive surgical procedures have entered the limelight within the global healthcare space. Incidences of surgical wounds and corresponding infections from conventional procedures have necessitated a shift towards alternative approaches. This has boded well for the laser therapy devices market. Medical practitioners are exhibiting a high tilt towards low level laser therapy (LLLT), amid a growing perception of it improving patient outcomes and reducing incidences of laser surgery associated side-effects in the long-run. Moreover, maximum applications are expected in cancer treatment, addressing ophthalmic disorders and aesthetics medicine.  A recent report from Future Market Insights&#39; (FMI) on the global <a xmlns="http://www.w3.org/1999/xhtml" href="https://www.futuremarketinsights.com/reports/laser-therapy-devices-market" target="_blank" rel="nofollow" rel="nofollow">laser therapy devices market </a>expects a healthy growth trend, reach a value of almost <span xmlns="http://www.w3.org/1999/xhtml" class="xn-money">US$ 2 billion</span> by 2022, registering a CAGR of around 4%. Long-term prospects also appear bright, with numerous large-scale investments underway to adopt laser treatment procedures, amid rising inclination towards minimally invasive surgeries.  The report said:&#34; As per FMI&#39;s analysis, oncology and aesthetics treatment are expected to emerge as key growth engines, followed by ophthalmology applications. Furthermore, preference for low level laser therapy (LLLT) is expected to increase, prompting key manufacturers to introduce a slew of innovative laser therapy devices solutions in the long-run.&#34;    Active companies in the markets this week include <b xmlns="http://www.w3.org/1999/xhtml">ShiftPixy, Inc</b>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ" rel="nofollow">PIXY</a>), <b xmlns="http://www.w3.org/1999/xhtml">Edwards Lifesciences Corporation </b>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE" rel="nofollow">EW</a>), <b xmlns="http://www.w3.org/1999/xhtml">Biofrontera</b> <b xmlns="http://www.w3.org/1999/xhtml">Inc.</b> <b xmlns="http://www.w3.org/1999/xhtml">(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ" rel="nofollow">BFRI</a>), </b><b xmlns="http://www.w3.org/1999/xhtml">Lumentum Holdings Inc. </b>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ" rel="nofollow">LITE</a>), <b xmlns="http://www.w3.org/1999/xhtml">Cutera, Inc. </b>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ" rel="nofollow">CUTR</a>).</p> <p xmlns="http://www.w3.org/1999/xhtml">The article added: &#34;According to the Cancer Atlas, there were an estimated 18.1 million active cases, with over 9 million cancer deaths in 2018. Additionally, nearly 44 million individual persons living with cancer that same year who were diagnosed within the previous&#39; five years. It is projected that this burden is expected to rise by over 60% by 2040. Hence, credible progress is expected to be made in this regard.  By device type, gas laser therapy devices to account for more than a quarter of the revenue share through 2021.  A fifth of the total laser therapy devices revenue is accounted for by hospitals, specialty clinics to generate over half of the total share.  ophthalmology treatment is likely to account for the bulk of the revenue share in the laser therapy devices market&#34;</p> <p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">ShiftPixy, Inc.</b> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ" rel="nofollow">PIXY</a>) BREAKING NEWS:  ShiftPixy Announces Quelliv Incubation Launch <b xmlns="http://www.w3.org/1999/xhtml"><i xmlns="http://www.w3.org/1999/xhtml">– </i></b>ShiftPixy (&#34;ShiftPixy&#34; or &#34;the Company&#34;), a <span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">Florida</span>-based national staffing enterprise which designs, manages, and sells access to a disruptive, revolutionary platform that facilitates employment in the rapidly growing Gig Economy, today announced the successful incubation launch of Quelliv Inc. low level laser centers which provide an effective, non-invasive therapeutic alternative to ease pain, reduce inflammation, enhance skin health, and activate personal well-being. Quelliv laser centers are powered by industry leader Genesis One Lasers to ensure effective sessions with long-lasting results.</p> <p xmlns="http://www.w3.org/1999/xhtml">&#34;After getting to know the science that powers Quelliv, we were very motivated to help incubate and position Quelliv for a very exciting growth journey,&#34; said ShiftPixy Co-Founder and Chief Executive ...</p><p><a href=https://www.benzinga.com/pressreleases/22/10/n29134483/global-laser-therapy-devices-billion-dollar-market-thriving-on-growing-demand alt=Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand>Full story available on Benzinga.com</a></p> Banking/Financial Services BFRI CUTR EW LITE PIXY Small Cap Opinion Press Releases Tue, 04 Oct 2022 12:30:00 +0000 PRNewswire 29134483 at https://www.benzinga.com Thinking about buying stock in PG&E Corp, Hess, Camber Energy, Carnival Corp, or AT&T? https://www.benzinga.com/pressreleases/22/10/n29120754/thinking-about-buying-stock-in-pg-e-corp-hess-camber-energy-carnival-corp-or-at-t <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 3, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3665720-1&amp;h=2554487330&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100320225&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for PCG, HES, CEI, CCL, and T.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29120754/thinking-about-buying-stock-in-pg-e-corp-hess-camber-energy-carnival-corp-or-at-t alt=Thinking about buying stock in PG&amp;E Corp, Hess, Camber Energy, Carnival Corp, or AT&amp;T?>Full story available on Benzinga.com</a></p> Banking/Financial Services CCL CEI HES PCG T Opinion Press Releases Mon, 03 Oct 2022 15:14:00 +0000 PRNewswire 29120754 at https://www.benzinga.com Staying Within Yourself - Trading Mindset https://www.benzinga.com/22/10/29119655/staying-within-yourself-trading-mindset <div> <div>Trading/investing, like any job or hobby in life takes skill, experience, preparation and patience to be successful. Learning to adapt, being flexible and making adjustments are also necessary. But there is also introspection, or knowing thyself. With wealth and riches unlimited (if done right) we are too often focused on the prize rather than the process and steps to get there. &nbsp;Ask yourself this question: &nbsp;Am I willing to do whatever it takes to be a successful trader/investor for the long haul?</div> <div>&nbsp;</div> <div>I recently had a small epiphany come through my recent trading. &nbsp;My results were not good, but my view of the markets and trading were actually very sharp. &nbsp;I just could not execute well, and was suffering under my own inability to get in sync with ...</div></div><p><a href=https://www.benzinga.com/22/10/29119655/staying-within-yourself-trading-mindset alt=Staying Within Yourself - Trading Mindset>Full story available on Benzinga.com</a></p> contributors MINDSET trading Opinion Opinion Benzinga Mon, 03 Oct 2022 14:22:25 +0000 Bob Lang 29119655 at https://www.benzinga.com Thinking about buying stock in Protagonist Therapeutics, BP, Nio, Axsome Therapeutics, or Petroleo Brasileiro? https://www.benzinga.com/pressreleases/22/10/n29118560/thinking-about-buying-stock-in-protagonist-therapeutics-bp-nio-axsome-therapeutics-or-petroleo-bra <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 3, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3665552-3&amp;h=4183147034&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100320222&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for PTGX, BP, NIO, AXSM, and PBR.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29118560/thinking-about-buying-stock-in-protagonist-therapeutics-bp-nio-axsome-therapeutics-or-petroleo-bra alt=Thinking about buying stock in Protagonist Therapeutics, BP, Nio, Axsome Therapeutics, or Petroleo Brasileiro?>Full story available on Benzinga.com</a></p> AXSM Banking/Financial Services BP NIO PBR PTGX Opinion Press Releases Mon, 03 Oct 2022 13:31:00 +0000 PRNewswire 29118560 at https://www.benzinga.com Thinking about trading options or stock in Apple, Exxon Mobil, Constellation Brands, Chesapeake Energy, or Laredo Petroleum? https://www.benzinga.com/pressreleases/22/10/n29118559/thinking-about-trading-options-or-stock-in-apple-exxon-mobil-constellation-brands-chesapeake-energ <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 3, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3665552-2&amp;h=2800178752&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fprnumber%3D100320223&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for AAPL, XOM, STZ, CHK, and LPI.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29118559/thinking-about-trading-options-or-stock-in-apple-exxon-mobil-constellation-brands-chesapeake-energ alt=Thinking about trading options or stock in Apple, Exxon Mobil, Constellation Brands, Chesapeake Energy, or Laredo Petroleum?>Full story available on Benzinga.com</a></p> AAPL Banking/Financial Services CHK LPI STZ XOM Opinion Press Releases Mon, 03 Oct 2022 13:31:00 +0000 PRNewswire 29118559 at https://www.benzinga.com Thinking about trading options or stock in Tesla, Occidental Petroleum, Freshpet, Devon Energy, or Chevron? https://www.benzinga.com/pressreleases/22/10/n29118558/thinking-about-trading-options-or-stock-in-tesla-occidental-petroleum-freshpet-devon-energy-or-che <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 3, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3665552-1&amp;h=2619541310&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fprnumber%3D100320224&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for TSLA, OXY, FRPT, DVN, and CVX.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29118558/thinking-about-trading-options-or-stock-in-tesla-occidental-petroleum-freshpet-devon-energy-or-che alt=Thinking about trading options or stock in Tesla, Occidental Petroleum, Freshpet, Devon Energy, or Chevron?>Full story available on Benzinga.com</a></p> Banking/Financial Services CVX DVN FRPT OXY TSLA Opinion Press Releases Mon, 03 Oct 2022 13:31:00 +0000 PRNewswire 29118558 at https://www.benzinga.com Thinking about buying stock in Myovant Sciences, Clovis Oncology, FingerMotion, LogicBio Therapeutics, or Amplify Energy? https://www.benzinga.com/pressreleases/22/10/n29116804/thinking-about-buying-stock-in-myovant-sciences-clovis-oncology-fingermotion-logicbio-therapeutics <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Oct. 3, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3665516-1&amp;h=4021263480&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D100320221&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for MYOV, CLVS, FNGR, LOGC, and AMPY.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/10/n29116804/thinking-about-buying-stock-in-myovant-sciences-clovis-oncology-fingermotion-logicbio-therapeutics alt=Thinking about buying stock in Myovant Sciences, Clovis Oncology, FingerMotion, LogicBio Therapeutics, or Amplify Energy?>Full story available on Benzinga.com</a></p> AMPY Banking/Financial Services CLVS FNGR LOGC MYOV Small Cap Opinion Press Releases Mon, 03 Oct 2022 12:30:00 +0000 PRNewswire 29116804 at https://www.benzinga.com Thinking about buying stock in Microsoft, Royal Caribbean Cruises, Meta, Boston Scientific, or Dick's Sporting Goods? https://www.benzinga.com/pressreleases/22/09/n29096977/thinking-about-buying-stock-in-microsoft-royal-caribbean-cruises-meta-boston-scientific-or-dicks-s <p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-location">NEW YORK</span></span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass"><span xmlns="http://www.w3.org/1999/xhtml" class="xn-chron">Sept. 30, 2022</span></span> /PRNewswire/ -- <a xmlns="http://www.w3.org/1999/xhtml" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3664354-1&amp;h=670118471&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D093020225&amp;a=InvestorsObserver" target="_blank" rel="nofollow" rel="nofollow">InvestorsObserver</a> issues critical PriceWatch Alerts for MSFT, RCL, META, BSX, and DKS.</p> <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p xmlns="http://www.w3.org/1999/xhtml"> <a xmlns="http://www.w3.org/1999/xhtml" href="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html" target="_blank" rel="nofollow" rel="nofollow"><br /> <img xmlns="http://www.w3.org/1999/xhtml" src="https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg" title="InvestorsObserver (PRNewsfoto/InvestorsObserver)" alt="InvestorsObserver (PRNewsfoto/InvestorsObserver)" /><br /> ...</a></p></div><p><a href=https://www.benzinga.com/pressreleases/22/09/n29096977/thinking-about-buying-stock-in-microsoft-royal-caribbean-cruises-meta-boston-scientific-or-dicks-s alt=Thinking about buying stock in Microsoft, Royal Caribbean Cruises, Meta, Boston Scientific, or Dick&#039;s Sporting Goods?>Full story available on Benzinga.com</a></p> Banking/Financial Services BSX DKS META MSFT RCL Opinion Press Releases Fri, 30 Sep 2022 14:45:00 +0000 PRNewswire 29096977 at https://www.benzinga.com